Menlo Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
REDWOOD CITY, Calif., March 03, 2020 (GLOBE NEWSWIRE) — Menlo Therapeutics Inc. (Nasdaq: MNLO), a late-stage biopharmaceutical company focused on […]
Nasdaq February 2020 Volumes
NEW YORK, March 03, 2020 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) today reported monthly volumes for February 2020, on its […]
Covetrus Names Benjamin Wolin Chief Executive Officer, Announces Fourth Quarter and Full Year 2019 Financial Results
Board of directors announces acting chief executive officer Benjamin Wolin to serve as president and CEO Fourth quarter net sales of […]
UNITY Biotechnology, Inc. to Announce Fourth Quarter and Full Year 2019 Financial Results
SAN FRANCISCO, March 03, 2020 (GLOBE NEWSWIRE) — UNITY Biotechnology, Inc. (UNITY) [NASDAQ:UBX], a biotechnology company developing therapeutics to extend […]
Cardlytics Announces Fourth Quarter and Fiscal Year 2019 Financial Results
ATLANTA, March 03, 2020 (GLOBE NEWSWIRE) — Cardlytics, Inc., (NASDAQ: CDLX), a purchase intelligence platform that makes marketing more relevant […]
TSX News -
Profound Medical Announces Fourth Quarter and Full Year 2019 Financial Results
TORONTO, March 03, 2020 (GLOBE NEWSWIRE) — Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device […]
Infrastructure and Energy Alternatives, Inc. Announces Conclusion of Rights Offering
INDIANAPOLIS, March 03, 2020 (GLOBE NEWSWIRE) — Infrastructure and Energy Alternatives, Inc. (“IEA” or the “Company”) (NASDAQ: IEA), a leading […]
Advaxis to Present at the 2020 LD Micro Virtual Conference
PRINCETON, N.J., March 03, 2020 (GLOBE NEWSWIRE) — Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development […]
Monroe Capital Corporation BDC Announces Fourth Quarter and Full Year 2019 Results
CHICAGO, March 03, 2020 (GLOBE NEWSWIRE) — Monroe Capital Corporation (Nasdaq: MRCC) (“Monroe”) today announced its financial results for the […]
Rubius Therapeutics to Report Fourth Quarter and Full-Year 2019 Financial Results and Host Webcast
CAMBRIDGE, Mass., March 03, 2020 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering […]
